ArticleCardiology and therapy2026

Mavacamten in Chinese Patients with Obstructive Hypertrophic Cardiomyopathy: Patient-Reported Health Status Analysis up to 78 Weeks in the EXPLORER-CN Study.

Zhuang Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.